Operating income decreased 60.4%
Operating income changed -60.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$947,000→$375,0003 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ACFN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue decreased 29.4%
Revenue changed -29.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$3.5M→$2.5M3 prior comparisons
Operating cash flow decreased 64.4%
Operating cash flow changed -64.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$629,000→$224,0004 prior comparisons
Operating margin moved 1180 bp lower
Operating margin changed -1180 basis points from the comparable as-filed period.
26.87%→15.07%3 prior comparisons
Stock-based compensation increased 209.4%
Stock-based compensation changed +209.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$32,000→$99,0004 prior comparisons
Gross margin moved 750 bp higher
Gross margin changed +750 basis points from the comparable as-filed period.
74.87%→82.36%3 prior comparisons
Cash & equivalents increased 37.7%
Cash & equivalents changed +37.7% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
$3.3M→$4.5M7 prior comparisons
Current liabilities decreased 19.8%
Current liabilities changed -19.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.1M→$3.3M4 prior comparisons
Working capital increased 35.1%
Working capital changed +35.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.7M→$3.7M4 prior comparisons
Trade receivables decreased 50.1%
Trade receivables changed -50.1% from the comparable as-filed period.
$2.1M→$1.1M3 prior comparisons
Gross profit decreased 22.3%
Gross profit changed -22.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$2.6M→$2.1M3 prior comparisons
Cost of revenue decreased 50.5%
Cost of revenue changed -50.5% from the comparable as-filed period.
$886,000→$439,0003 prior comparisons
Inventory / revenue moved 1824 bp higher
Inventory / revenue changed +1824 basis points from the comparable as-filed period.
27.04%→45.28%3 prior comparisons
Operating cash-flow margin moved 884 bp lower
Operating cash-flow margin changed -884 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
17.84%→9.00%3 prior comparisons
SBC / revenue moved 307 bp higher
SBC / revenue changed +307 basis points from the comparable as-filed period.
0.91%→3.98%3 prior comparisons
Working capital / assets moved 578 bp higher
Working capital / assets changed +578 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
21.77%→27.55%4 prior comparisons
Receivables / revenue moved 1780 bp lower
Receivables / revenue changed -1780 basis points from the comparable as-filed period.
60.71%→42.91%2 prior comparisons
Current ratio increased 27.4%
Current ratio changed +27.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.67→2.124 prior comparisons
Research & development decreased 9.8%
Research & development changed -9.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$265,000→$239,0003 prior comparisons
Inventory increased 18.3%
Inventory changed +18.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$953,000→$1.1M4 prior comparisons
Total assets increased 6.8%
Total assets changed +6.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$12.5M→$13.4M4 prior comparisons
R&D / revenue moved 208 bp higher
R&D / revenue changed +208 basis points from the comparable as-filed period.
7.52%→9.60%3 prior comparisons
Shares outstanding increased 0.3%
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
2,501,440→2,509,6188 prior comparisons
Current assets increased 2.2%
Current assets changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.8M→$7.0M4 prior comparisons
Selling, general & administrative increased 0.6%
Selling, general & administrative changed +0.6% from the comparable as-filed period.
$1.4M→$1.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.